Skip to main content

Global Vitiligo Foundation

EIN: 81-3950571Mechanicsburg, PAZIP: 17050
H90 - Medical Research501(c)(3)

Mission

To develop international standards of care in effective treatments, to find a cure, to support education and advocacy, and to raise public awareness of Vitiligo.

Financials

YearRevenueExpensesAssets
2023$479k$0$213k

Compensation

Pearl Grimes MD
$0
$0
$0
$0
Iltefat Hamzavi MD FAAD
$0
$0
$0
$0
John E Harris MD PhD
$0
$0
$0
$0
Richard Huggins MD
$0
$0
$0
$0
Amit G Pandya MD
$0
$0
$0
$0
Efrem Kamen
$0
$0
$0
$0
Davinder Parsad MD FRCP
$0
$0
$0
$0
Harvey Lui MD
$0
$0
$0
$0
Samia Esmat MD
$0
$0
$0
$0
Stephen Taylor
$0
$0
$0
$0
Nada Elbuluk MD MSc FAAD
$0
$0
$0
$0

Similar Organizations

$590k revenue
Similar sector (H)Similar revenue ($590k vs $479k)Same state (Pennsylvania)Similar median compensation ($93k vs $84k)Similar size (12 vs 13 executives)
$659k revenue
Same sector (H90)Comparable revenue ($659k vs $479k)Same state (Pennsylvania)
$445k revenue
Similar sector (H)Very similar revenue ($445k vs $479k)Same state (Pennsylvania)
ALS Hope Foundation

Philadelphia, PA

$549k revenue
Similar sector (H)Similar revenue ($549k vs $479k)Same state (Pennsylvania)Comparable compensation levelsSimilar size (11 vs 13 executives)
Similar sector (H)Similar revenue ($394k vs $479k)Same state (Pennsylvania)Similar size (13 vs 13 executives)
$594k revenue
Similar sector (H)Similar revenue ($594k vs $479k)Same state (Pennsylvania)Similar size (11 vs 13 executives)
$369k revenue
Similar sector (H)Similar revenue ($369k vs $479k)Same state (Pennsylvania)Similar size (12 vs 13 executives)
THE RYR-1 FOUNDATION

Pittsburgh, PA

$600k revenue
Similar sector (H)Comparable revenue ($600k vs $479k)Same state (Pennsylvania)Similar size (14 vs 13 executives)
ARTZ PHILADELPHIA

Philadelphia, PA

$348k revenue
Similar sector (H)Comparable revenue ($348k vs $479k)Same state (Pennsylvania)
$284k revenue
Similar sector (H)Comparable revenue ($284k vs $479k)Same state (Pennsylvania)
Data from IRS Form 990 filings (2023).